NASDAQ : DH
Definitive Healthcare Corp. — Key statistics
Healthcare · Health Information Services · United States
Last price 1.11 USD (Oct 30, 2026, 2:05 PM EDT) · Market cap 160.77M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 162.22M |
| Enterprise Value | 145.47M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 106.74M |
| Shares Outstanding | 144.84M |
| Shares Change (YoY) | -7.41% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 3.49% |
| Owned by Institutions (%) | 24.24% |
| Float | 40.43M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | 6.41 |
| PS Ratio | 0.70 |
| Forward PS | 0.73 |
| PB Ratio | 0.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 5.68 |
| P/OCF Ratio | 3.92 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.63 |
| EV / EBITDA | 4.12 |
| EV / EBIT | n/a |
| EV / FCF | 5.09 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.86 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 4.46 |
| Debt / FCF | 5.85 |
| Interest Coverage | -1.77 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -78.37% |
| Return on Assets (ROA) | -1.94% |
| Return on Invested Capital (ROIC) | -2.60% |
| Return on Capital Employed (ROCE) | -5.34% |
| Weighted Average Cost of Capital (WACC) | 8.54% |
| Revenue Per Employee | $339,219 |
| Profits Per Employee | -$245,184 |
| Employee Count | 686 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | -3.31M |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.40 |
| 52-Week Price Change | -59.57% |
| 50-Day Moving Average | 0.98 |
| 200-Day Moving Average | 1.08 |
| Relative Strength Index (RSI) | 63.95 |
| Average Volume (20 Days) | 336,488 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.93M |
| Short Previous Month | 1.68M |
| Short % of Shares Out | 1.33% |
| Short % of Float | 4.76% |
| Short Ratio (days to cover) | 2.72 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 232.70M |
| Gross Profit | 194.92M |
| Operating Income | -19.65M |
| Pretax Income | -238.05M |
| Net Income | -168.20M |
| EBITDA | 35.33M |
| EBIT | -19.65M |
| Loss Per Share | -$1.61 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 183.81M |
| Total Debt | 167.06M |
| Net Cash | 16.75M |
| Net Cash Per Share | $0.12 |
| Equity (Book Value) | 187.87M |
| Book Value Per Share | 1.36 |
| Working Capital | 111.03M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 41.43M |
| Capital Expenditures | -12.87M |
| Depreciation & Amortization | 54.98M |
| Net Borrowing | -8.75M |
| Free Cash Flow | 28.56M |
| FCF Per Share | $0.20 |
Margins
| Measure | Value |
|---|
| Gross Margin | 83.76% |
| Operating Margin | -8.45% |
| Pretax Margin | -102.30% |
| Profit Margin | -72.28% |
| EBITDA Margin | 15.18% |
| EBIT Margin | -8.45% |
| FCF Margin | 12.27% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 7.41% |
| Shareholder Yield | 7.41% |
| Earnings Yield | -143.87% |
| FCF Yield | 17.61% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $1.63 |
| Price Target Difference | 45.09% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | -2.77% |
| EPS Growth Forecast (3Y) | -8.31% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -1.51 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |